Based on the ingenious combination of two different gradient generation mechanisms, this work reports a novel approach for a high throughput linear liquid gradient in a two-dimensional (2D) matrix. Specifically, a typical Christmas Tree structure with two inlets was designed as the first mixture gradient generator, upon which the second diffusion gradient generator was coupled to produce the desired concentration series on the basis of the distance difference. Rather than a simple 1D line, the integration of the two generators would result in an innovative 2D matrix of reservoirs, which was then characterized both theoretically and experimentally. Theoretically, calculation of fluid field demonstrated the formation of a concentration gradient, which was then confirmed by the dye solution visualization analysis. For high throughput screening application, doxorubicin (Dox) was then selected as model medicine to treat the acute myeloblastic leukemia (HL-60) cells. Cell viability displayed that cell death rate enhanced with the increase of drug concentration, and this result was higher than that on a 96-well plate, and the corresponding mechanism was properly discussed. Subsequently, Dox and quercetin were employed simultaneously to generate an overlapping gradient and its effect on HL-60 cells was investigated. Due to the automatic formation of concentration gradient that could improve the work efficiency, this work provides a promising tool for future high throughput drug screening.

1.
S. A.
Sundberg
,
Curr. Opin. Biotechnol.
11
,
47
(
2000
).
2.
A. L.
Harvey
,
Planta Med.
76
,
1080
(
2010
).
3.
B. H.
Weigl
,
R. L.
Bardell
, and
C. R.
Cabrera
,
Adv. Drug Delivery Rev.
55
,
349
(
2003
).
4.
J. J.
Diaz-Mochon
,
T.
Guilhem
, and
M.
Bradley
,
Chem. Soc. Rev.
36
,
449
(
2007
).
5.
P.
Neuzil
,
S.
Giselbrecht
,
K.
Lange
,
T. J.
Huang
, and
A.
Manz
,
Nat. Rev. Drug Discovery
11
,
620
(
2012
).
6.
S.
Fox
,
J. Biomol. Screening
9
,
354
(
2004
).
7.
E.
Delamarche
,
A.
Bernard
,
H.
Schmid
,
A.
Bietsch
,
B.
Michel
, and
H.
Biebuyck
,
J. Am. Chem. Soc.
120
,
500
(
1998
).
8.
T. M.
Keenan
and
A.
Folch
,
Lab Chip
8
,
34
(
2008
).
9.
T.
Odake
,
M.
Tabuchi
,
T.
Sato
,
H.
Susaki
, and
T.
Korenaga
,
Anal. Sci.
17
,
535
(
2001
).
10.
J.
Atencia
,
G. A.
Cooksey
, and
L. E.
Locascio
,
Lab Chip
12
,
309
(
2012
).
11.
N. L.
Jeon
,
S. K. W.
Dertinger
,
D. T.
Chiu
,
I. S.
Choi
,
A. D.
Stroock
, and
G. M.
Whitesides
,
Langmuir
16
,
8311
(
2000
).
12.
A.
Ahmadi
,
H.
Najjaran
,
J. F.
Holzman
, and
M. J.
Hoorfar
,
J. Micromech. Microeng.
19
,
065003
(
2009
).
13.
H.
Huang
,
X. L.
Mao
,
S. C. S.
Lin
,
B.
Kiraly
,
Y. P.
Huang
, and
T. J.
Huang
,
Lab Chip
10
,
2387
(
2010
).
14.
B. Y.
Xu
,
S. W.
Hu
,
G. S.
Qian
,
J. J.
Xu
, and
H. Y.
Chen
,
Lab Chip
13
,
3714
(
2013
).
15.
B. Y.
Xu
,
S. W.
Hu
,
J. J.
Xu
, and
H. Y.
Chen
,
Lab Chip
12
,
1281
(
2012
).
16.
B. Y.
Xu
,
X. N.
Yan
,
J. D.
Zhang
,
J. J.
Xu
, and
H. Y.
Chen
,
Lab Chip
12
,
381
(
2012
).
17.
M.
Yamada
,
T.
Hirano
,
M.
Yasuda
, and
M.
Seki
,
Lab Chip
6
,
179
(
2006
).
18.
W.
Dai
,
Y. Z.
Zheng
,
K. Q.
Luo
, and
H. K.
Wu
,
Biomicrofluidics
4
,
024101
(
2010
).
19.
J.
Atencia
,
J.
Morrow
, and
L. E.
Locascio
,
Lab Chip
9
,
2707
(
2009
).
20.
See supplementary material at http://dx.doi.org/10.1063/1.4847815 for FS1 A-D and FS2.
21.
C. M.
Perou
,
T.
Sorlie
,
M. B.
Eisen
,
M.
van de Rijn
,
S. S.
Jeffrey
,
C. A.
Rees
,
J. R.
Pollack
,
D. T.
Ross
,
H.
Johnsen
,
L. A.
Akslen
,
O.
Fluge
,
A.
Pergamenschikov
,
C.
Williams
,
S. X.
Zhu
,
P. E.
Lonning
,
A. L.
Borresen-Dale
,
P. O.
Brown
, and
D.
Botstein
,
Nature
406
,
747
(
2000
).
22.
M. A.
Shipp
,
D. P.
Harrington
,
J. R.
Anderson
,
J. O.
Armitage
,
G.
Bonadonna
,
G.
Brittinger
,
F.
Cabanillas
,
G. P.
Canellos
,
B.
Coiffier
,
J. M.
Connors
,
R. A.
Cowan
,
D.
Crowther
,
S.
Dahlberg
,
M.
Engelhard
,
R. I.
Fisher
,
C.
Gisselbrecht
,
S. J.
Horning
,
E.
Lepage
,
T. A.
Lister
,
J. H.
Meerwaldt
,
E.
Montserrat
,
N. I.
Nissen
,
M. M.
Oken
,
B. A.
Peterson
,
C.
Tondini
,
W. A.
Velasquez
, and
B. Y.
Yeap
,
N. Engl. J. Med.
329
,
987
(
1993
).
23.
B.
Coiffier
,
E.
Lepage
,
J.
Briere
,
R.
Herbrecht
,
H.
Tilly
,
R.
Bouabdallah
,
P.
Morel
,
E.
Van den Neste
,
G.
Salles
,
P.
Gaulard
,
F.
Reyes
, and
C.
Gisselbrecht
,
N. Engl. J. Med.
346
,
235
(
2002
).
24.
A.
Webb
,
D.
Cunningham
,
J. H.
Scarffe
,
P.
Harper
,
A.
Norman
,
J. K.
Joffe
,
M.
Hughes
,
J.
Mansi
,
M.
Findlay
,
A.
Hill
,
J.
Oates
,
M.
Nicolson
,
T.
Hickish
,
M.
Obrien
,
T.
Iveson
,
M.
Watson
,
C.
Underhill
,
A.
Wardley
, and
M.
Meehan
,
J. Clin. Oncol.
15
,
261
(
1997
).
25.
D.
Staedler
,
E.
Idrizi
,
B. H.
Kenzaoui
, and
L.
Juillerat-Jeanneret
,
Cancer Chemother. Pharmacol.
68
,
1161
(
2011
).
26.
L. P.
Swift
,
A.
Rephaeli
,
A.
Nudelman
,
D. R.
Phillips
, and
S. M.
Cutts
,
Cancer Res.
66
,
4863
(
2006
).

Supplementary Material

You do not currently have access to this content.